We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$513M
AUM Growth
+$30.9M
Cap. Flow
-$21.7M
Cap. Flow %
-4.24%
Top 10 Hldgs %
65.73%
Holding
42
New
1
Increased
3
Reduced
7
Closed

Top Buys

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$4.96M
2
GE icon
GE Aerospace
GE
+$4.15M
3
BHC icon
Bausch Health
BHC
+$3.9M
4
FATE icon
Fate Therapeutics
FATE
+$794K

Sector Composition

Rank Sector Weight
1 Healthcare 30.6%
2 Utilities 28.86%
3 Industrials 12.48%
4 Technology 8.01%
5 Financials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHAL icon
1
U-Haul Holding Co
UHAL
$13.9B
$53.9M 10.51%
1,433,520
-62,330
-4% -$2.37M
NEE icon
2
NextEra Energy
NEE
$185B
$47.7M 9.3%
787,200
ALL icon
3
Allstate
ALL
$64.3B
$34.8M 6.8%
309,800
BHC icon
4
Bausch Health
BHC
$1.8B
$34.1M 6.66%
1,141,000
+150,000
+15% +$3.9M
CMS icon
5
CMS Energy
CMS
$22.8B
$31M 6.04%
492,800
MRK icon
6
Merck
MRK
$315B
$29.7M 5.8%
342,591
DUK icon
7
Duke Energy
DUK
$97.5B
$29.5M 5.75%
323,000
XEL icon
8
Xcel Energy
XEL
$49.2B
$27.7M 5.4%
436,100
AAPL icon
9
Apple
AAPL
$4.9T
$25.7M 5.02%
350,400
ABBV icon
10
AbbVie
ABBV
$450B
$22.8M 4.45%
257,800
ABT icon
11
Abbott
ABT
$175B
$22.1M 4.31%
254,600
PFE icon
12
Pfizer
PFE
$143B
$20.3M 3.96%
545,795
IBM icon
13
IBM
IBM
$200B
$15.4M 3%
119,819
-1,569
-1% -$204K
AGN
14
DELISTED
Allergan plc
AGN
$11.6M 2.27%
60,900
-20,000
-25% -$3.61M
AVA icon
15
Avista
AVA
$3.45B
$10M 1.96%
208,500
SIRI icon
16
SiriusXM
SIRI
$10.3B
$9.71M 1.89%
135,784
GE icon
17
GE Aerospace
GE
$364B
$9.49M 1.85%
170,541
+80,255
+89% +$4.15M
CMP icon
18
Compass Minerals
CMP
$1.24B
$8.53M 1.67%
140,000
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$2.79B
$8.35M 1.63%
352,105
+204,047
+138% +$4.96M
GM icon
20
General Motors
GM
$68.6B
$7.32M 1.43%
200,000
-50,000
-20% -$1.82M
FOCL
21
EDAP TMS S.A.
FOCL
$204M
$3.66M 0.71%
825,536
NEM icon
22
Newmont
NEM
$95.8B
$2.82M 0.55%
65,000
WEC icon
23
WEC Energy
WEC
$36.9B
$2.13M 0.42%
23,124
RLI icon
24
RLI Corp
RLI
$5.66B
$2.05M 0.4%
45,600
ASH icon
25
Ashland
ASH
$3.14B
$1.91M 0.37%
25,000

Similar funds

Bruce & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Bruce & Co held 42 positions worth $513M, up 6.4% from $482M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bruce & Co withdrew a net $21.7M in Q4 2019, reducing 7 holdings. Its largest reduction was Allergan plc, cutting an estimated $3.61M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 28% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Fate Therapeutics worth $978K.

  • Bruce & Co's largest Q4 2019 buy was Fate Therapeutics: 50,000 shares worth $978K.
  • Bruce & Co added most to Supernus Pharmaceuticals in Q4 2019, an estimated $4.96M increase.
  • Bruce & Co's biggest Q4 2019 reduction was Allergan plc, cutting an estimated $3.61M.
  • Bruce & Co's ten largest holdings make up 66% of its $513M portfolio in Q4 2019.
  • Bruce & Co opened 1 new position and closed 0 in Q4 2019.
  • Bruce & Co's portfolio value rose 6.4% quarter-over-quarter to $513M.

Based on Bruce & Co's 13F filing for Q4 2019, filed 14 Feb 2020.